Document Detail

Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care.
MedLine Citation:
PMID:  20135088     Owner:  NLM     Status:  MEDLINE    
AIMS/HYPOTHESIS: This study aims to evaluate the cost-effectiveness of a screening programme for pre-diabetes, which was followed up by treatment with pharmaceutical interventions (acarbose, metformin, orlistat) or lifestyle interventions (diet, exercise, diet and exercise) in order to prevent or slow the onset of diabetes in those at high risk. METHODS: To approximate the experience of individuals with pre-diabetes in the Australian population, we used a microsimulation approach, following patient progression through diabetes, cardiovascular disease and renal failure. The model compares costs and disability-adjusted life years lived in people identified through an opportunistic screening programme for each intervention compared with a 'do nothing' scenario, which is representative of current practice. It is assumed that the effect of a lifestyle change will decay by 10% per year, while the effect of a pharmaceutical intervention remains constant throughout use. RESULTS: The most cost-effective intervention options are diet and exercise combined, with a cost-effectiveness ratio of AUD 22,500 per disability-adjusted life year (DALY) averted, and metformin with a cost-effectiveness ratio of AUD 21,500 per DALY averted. The incremental addition of one intervention to the other is not cost-effective. CONCLUSIONS/INTERPRETATION: Screening for pre-diabetes followed by diet and exercise, or metformin treatment is cost-effective and should be considered for incorporation into current practice. The number of dietitians and exercise physiologists needed to deliver such lifestyle change interventions will need to be increased to appropriately support the intervention.
M Y Bertram; S S Lim; J J Barendregt; T Vos
Related Documents :
11559268 - Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a me...
9781318 - Training effects on muscle glucose transport during exercise.
24736778 - The effect of wave conditions and surfer ability on performance and the physiological r...
6987518 - Increased insulin receptors after exercise in patients with insulin-dependent diabetes ...
15304378 - Insulin facilitation of muscle protein synthesis following resistance exercise in hindl...
16468058 - Mechanically versus electro-magnetically braked cycle ergometer: performance and energy...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-02-05
Journal Detail:
Title:  Diabetologia     Volume:  53     ISSN:  1432-0428     ISO Abbreviation:  Diabetologia     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-07     Completed Date:  2010-06-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0006777     Medline TA:  Diabetologia     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  875-81     Citation Subset:  IM    
Centre for Burden of Disease and Cost-Effectiveness, School of Population Health, The University of Queensland, Herston Rd, Herston, Queensland 4006, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cost-Benefit Analysis / economics
Diabetes Mellitus, Type 2 / economics*,  epidemiology,  prevention & control*
Diet / economics
Hypoglycemic Agents / economics,  therapeutic use
Life Style
Mass Screening / economics*
Metformin / economics,  therapeutic use
Middle Aged
Prediabetic State / drug therapy,  economics*,  epidemiology
Quality of Life
Regression Analysis
Risk Factors
Reg. No./Substance:
0/Hypoglycemic Agents; 657-24-9/Metformin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Endoscopic palliation of esophageal and bronchial carcinomas.
Next Document:  The relationship of comorbidity of mental and substance use disorders with suicidal behaviors in the...